Register for our S/EIS Fund

A passion for

measured risk

We are constantly innovating our people, project management and technology models leading to outstanding results for our collaborators. The world’s first app based technology platform Chemistry in the CloudTM enables us to work together to make faster decisions. Our deep understanding that an early and intensive evaluation of target molecules based on real insight into the science will lead to faster downstream execution. The result is a higher throughput of successful drug-like compounds.

Press Release – Curza and o2h discovery announce a multi-FTE chemistry collaboration against gram negative

Our in-house projects

Opal

Opal Oncology is a drug discovery company incorporated in 2012 and is based in Cambridge, UK. We have a vision for discovering and in-licensing small molecule cancer therapies.